Back to results
US 8,409,619 B2Granted
Oral drug delivery system for azole, moxifloxacin and rifampicin
AssigneeLifecare Innovations Pvt. Ltd.
InventorsGopal Krishan Khuller, Jitendra Nath Verma
Life of this patent
Estimating the term…
Abstract
An oral drug delivery system for treatment of tuberculosis is described. The oral drug delivery system includes (e.g., a mixture or combination of): poly DL-lactide-co-glycolide nano particles having encapsulated an azole therein; poly DL-lactide-co-glycolide nano particles having moxifloxacin encapsulated therein; and poly DL-lactide-co-glycolide nano particles having RIF encapsulated therein.
Claims3
An oral drug delivery system for treatment of tuberculosis comprising:
- a) poly DL-lactide-co-glycolide nanoparticles having enconazole encapsulated therein;
- b) poly DL-lactide-co-glycolide nanoparticles having moxifloxacin encapsulated therein;
- and
- c) poly DL-lactide-co-glycolide nanoparticles having rifampicin encapsulated therein.
1 more element
Dependencies are inferred from the claim text.